Product Images Oxybutynin Chloride Extended Release
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 10 images provide visual information about the product associated with Oxybutynin Chloride Extended Release NDC 64980-210 by Rising Pharma Holdings, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Oxybutynin Chloride Extended Release Tablets USP 10mg 100 ct label
Oxybutynin Chloride Extended Release Tablets USP 15mg 100 ct label
Oxybutynin Chloride Extended Release Tablets USP 5mg 100 ct label
A useful description cannot be generated from the provided text. It appears to be a mix of different characters and does not form coherent sentences or words. It is possible that the text was not recognized by correctly.*
figure 1 - fig 1
The text provides a graph titled "Mean Plasma R-Oxybutynin Concentration (ng/mL)" comparing the concentrations of oxybutynin chloride extended-release tablets at 10 mg once daily versus oxybutynin at 5 mg three times daily over a period of 16 hours. Therefore, the text describes the pharmacokinetics of two different dosing regimens of oxybutynin.*
figure 2 - fig 2
figure 3
figure 4
Oxybutynin is a medication that is available in extended-release tablets. Unfortunately, no additional information is available from the provided text.*
figure 5
This text appears to be a list of components of a medication. Specifically, it includes the name of the medication "Oxybutynin chloride" and the presentation of the tablets "extended-release".*
rising logo
structure - structural formula
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.